Showing results (131-140 of 901) with videos related to

Sort By:
Pageof 91
Journal of Hepatology|November 16, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference<sup>‡</sup>Markus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.
Hepatology (Baltimore, Md.)|January 12, 2002
Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitisArndt Vogel, Christian P Strassburg, Michael P Manns
Clinics in Liver Disease|October 5, 2002
Autoimmunity and virusesArndt Vogel, Michael P Manns, Christian P Strassburg
Clinics in Liver Disease|August 27, 2011
Second-wave protease inhibitors: choosing an heirSandra Ciesek, Thomas von Hahn, Michael P Manns
Hepatology (Baltimore, Md.)|November 13, 2019
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints ConferenceMarkus Cornberg, Anna Suk-Fong Lok, Norah A Terrault, et al.
Innere Medizin (Heidelberg, Germany)|September 23, 2024
[Hepatotoxicity due to albendazole: safe alternatives for echinococcosis therapy]Laura Muana Wilhelm, Joschka Bachmann, Markus Cornberg, et al.
The Journal of Infectious Diseases|October 25, 2013
Compromised function of natural killer cells in acute and chronic viral hepatitisSebastian Lunemann, David F G Malone, Julia Hengst, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis deltaBenjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, et al.
Nature|November 22, 2011
Natural killer cells act as rheostats modulating antiviral T cellsStephen N Waggoner, Markus Cornberg, Liisa K Selin, et al.
United European Gastroenterology Journal|December 22, 2020
Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patientsSolomon Owusu Sekyere, Kerstin Port, Katja Deterding, et al.
Pageof 91